Joseph R Mikhael (Joseph Mikhael)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Multiple Myeloma

Ejection Fraction

Top Venues

Blood cancer journal

Current oncology (Toronto, Ont.)

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Rahul Banerjee, Joseph R Mikhael
How can we stamp out high-risk myeloma? Blood 143 (20) (2024)
Rahul Banerjee, Joseph R Mikhael
How can we stamp out high-risk myeloma? Blood 143 (20) (2024)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rahul Banerjee, Louis Williams, Joseph R Mikhael
Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma. Blood cancer journal 13 (1) (2023)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani, Ajay K Nooka, Leon Bernal-Mizrachi, Joseph R Mikhael
Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Joseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, Cherilyn L Heggen, Lindsay M Gurska
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology Centers. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Meletios- Athanasios Dimopoulos, Phillipe Moreau, Bradley Augustson, Nelson Castro, Tomas Pika, Sosana Delimpasi, Javier De la Rubia, Angelo Maiolino, Tony Reiman, Joaquin Martinez-Lopez, Thomas Martin, Joseph R Mikhael, Kwee Yong, Marie-Laure Risse, Gaelle Asset, Sylvia Marion, Roman Hajek
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. American journal of hematology (2022)
Joseph R Mikhael, Jessica Fowler, Nina Shah
Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access. JCO oncology practice (2022)
Thomas Martin, Joseph R Mikhael, Roman Hájek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatyana S Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma. Blood advances 6 (15) (2022)
Joseph R Mikhael, Erin Singh, Megan S Rice
Real-world renal function among patients with multiple myeloma in the United States. Blood cancer journal 11 (5) (2021)
Sundar Jagannath, Joseph R Mikhael, Omar Nadeem, Noopur Raje
Digital Health for Patients With Multiple Myeloma: An Unmet Need. JCO clinical cancer informatics 5 (2021)
Kristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, Mark Fiala, Martin Schoen, Tanya M Wildes, Joseph R Mikhael, Nicole M Kuderer, David C Calverley, Jesse Keller, Theodore Thomas, Kenneth R Carson, Brian F Gage
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. American journal of hematology 94 (11) (2019)